Fusion Fund is on record against 51 companies.
Early-stage investor in deep-tech, targeting defensible AI, advanced materials, and industry automation, including medical devices. Focuses on data-moat startups with no explicit geographic limit, leveraging Lu Zhang’s R&D and entrepreneurial credibility.